We are live on ! Find out more
Wealthfront Advisers

Wealthfront Advisers Portfolio holdings

AUM $52B
1-Year Est. Return 24.53%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+24.53%
3 Year Est. Return
+63.26%
5 Year Est. Return
+56.07%
10 Year Est. Return
AUM
$52B
AUM Growth
+$6.48B
Cap. Flow
+$1.17B
Cap. Flow %
2.26%
Top 10 Hldgs %
56.09%
Holding
1,138
New
62
Increased
608
Reduced
447
Closed
19
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDRX icon
1101
GoodRx Holdings
GDRX
$1.2B
$81.6K ﹤0.01%
28,342
+212
+0.8% +$539
CABA icon
1102
Cabaletta Bio
CABA
$529M
$75.8K ﹤0.01%
+24,389
New +$80.2K
ALIT icon
1103
Alight
ALIT
$374M
$70.9K ﹤0.01%
6,333
NFE icon
1104
New Fortress Energy
NFE
$83.6M
$70.8K ﹤0.01%
195,062
-884
-0.5% -$526
PACB icon
1105
Pacific Biosciences
PACB
$435M
$66.4K ﹤0.01%
39,511
+65
+0.2% +$95
CHGG icon
1106
Chegg
CHGG
$93.7M
$63.2K ﹤0.01%
62,585
-964
-2% -$1.06K
SPCE icon
1107
Virgin Galactic
SPCE
$446M
$57K ﹤0.01%
+19,712
New +$64.4K
SOC icon
1108
Sable Offshore Corp
SOC
$861M
$56.6K ﹤0.01%
18,384
+861
+5% +$11K
RXRX icon
1109
Recursion Pharmaceuticals
RXRX
$1.79B
$54.4K ﹤0.01%
14,820
+2,610
+21% +$8.69K
IOVA icon
1110
Iovance Biotherapeutics
IOVA
$3.63B
$53.9K ﹤0.01%
+12,959
New +$49.2K
ABAT icon
1111
American Battery Technology Co
ABAT
$351M
$52K ﹤0.01%
18,384
+1,047
+6% +$3.35K
INDI icon
1112
indie Semiconductor
INDI
$799M
$48K ﹤0.01%
+10,695
New +$42.7K
AQST icon
1113
Aquestive Therapeutics
AQST
$630M
$44.4K ﹤0.01%
10,679
-1,448
-12% -$6.09K
PRME icon
1114
Prime Medicine
PRME
$655M
$41.7K ﹤0.01%
11,301
+922
+9% +$3.06K
JELD icon
1115
JELD-WEN Holding
JELD
$220M
$34.2K ﹤0.01%
22,785
HTZ icon
1116
Hertz
HTZ
$763M
$26.8K ﹤0.01%
+11,835
New +$64.6K
BLNK icon
1117
Blink Charging
BLNK
$77.2M
$21.9K ﹤0.01%
34,166
-107
-0.3% -$77
GPRO icon
1118
GoPro
GPRO
$111M
$10.5K ﹤0.01%
13,494
-51
-0.4% -$54
XRXDW
1119
Xerox Holdings Corp Warrants
XRXDW
$22.7M
$3.35K ﹤0.01%
12,194
-426
-3% -$116
CC icon
1120
Chemours
CC
$2.35B
-42,567
Closed -$938K
CHWY icon
1121
Chewy
CHWY
$9.52B
-8,050
Closed -$217K
CLOV icon
1122
Clover Health Investments
CLOV
$2.25B
-13,023
Closed -$22.9K
CTRA
1123
DELISTED
Coterra Energy
CTRA
-165,091
Closed -$5.8M
DFAS icon
1124
Dimensional US Small Cap ETF
DFAS
$15.6B
-2,833
Closed -$202K
HOLX
1125
DELISTED
Hologic
HOLX
-61,471
Closed -$4.65M

Similar funds

Wealthfront Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Wealthfront Advisers held 1,138 positions worth $52B, up 14% from $45.6B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Wealthfront Advisers's Q2 2026 filing shows 62 new, 608 increased, 447 reduced and 19 closed positions. Its largest new stake was Honeywell Aerospace: 54,444 shares worth $12M. The largest sale was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $70M.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, down from 82% a quarter earlier, followed by Technology and Financials.

  • Wealthfront Advisers's largest Q2 2026 buy was Honeywell Aerospace: 54,444 shares worth $12M.
  • Wealthfront Advisers added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2026, an estimated $185M increase.
  • Wealthfront Advisers's biggest Q2 2026 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $70M.
  • Wealthfront Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $5.8M.
  • Wealthfront Advisers's ten largest holdings make up 56% of its $52B portfolio in Q2 2026.
  • Wealthfront Advisers opened 62 new positions and closed 19 in Q2 2026.
  • Wealthfront Advisers's portfolio value rose 14% quarter-over-quarter to $52B.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.